Literature DB >> 16678378

Sensitivity and specificity of nested and real-time PCR for the detection of Pneumocystis jiroveci in clinical specimens.

Míriam J Alvarez-Martínez1, José M Miró, Maria Eugenia Valls, Asunción Moreno, Paula V Rivas, Manel Solé, Natividad Benito, Pere Domingo, Carmen Muñoz, Esteban Rivera, Heather J Zar, Gustavo Wissmann, Ada R S Diehl, João C Prolla, Maria Teresa Jiménez de Anta, José M Gatell, Paul E Wilson, Steven R Meshnick.   

Abstract

A polymerase chain reaction (PCR)-based test for Pneumocystis jiroveci (formerly Pneumocystis carinii f. sp. hominis) might be an alternative to histologic diagnoses of P. jiroveci pneumonia (PCP). However, previously developed nested PCR methods tend to have low specificities (high false-positive rates). In this study, nested and quantitative real-time PCR methods for the amplification of the P. jiroveci DHPS (dihydropteroate synthase) gene were evaluated in a variety of stored clinical samples from Spain, South Africa, and Brazil. The sensitivities of both assays were high, ranging from 62.5% to 100% depending on the type of specimen. In a subset of 71 microscopically confirmed PCP cases and 70 negative cases, the sensitivities and specificities were 94% and 81% for nested PCR and 94% and 96% for real-time PCR, respectively. Real-time PCR has a statistically significantly better specificity than nested PCR (P = .015) and is likely to generate fewer false positives.

Entities:  

Mesh:

Year:  2006        PMID: 16678378     DOI: 10.1016/j.diagmicrobio.2006.03.010

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  28 in total

Review 1.  Update on the diagnosis and treatment of Pneumocystis pneumonia.

Authors:  Eva M Carmona; Andrew H Limper
Journal:  Ther Adv Respir Dis       Date:  2010-08-24       Impact factor: 4.031

Review 2.  Molecular and nonmolecular diagnostic methods for invasive fungal infections.

Authors:  Marios Arvanitis; Theodora Anagnostou; Beth Burgwyn Fuchs; Angela M Caliendo; Eleftherios Mylonakis
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

Review 3.  Infections in the immunosuppressed host.

Authors:  M Patricia George; Henry Masur; Karen A Norris; Scott M Palmer; Cornelius J Clancy; John F McDyer
Journal:  Ann Am Thorac Soc       Date:  2014-08

4.  Prevalence of Pneumocystis jirovecii among immunocompromised patients in hospitals of Tehran city, Iran.

Authors:  Mohammad Mohsen Homayouni; Hamed Behniafar; Amir Sayed Ali Mehbod; Mohammad-Javad Mohammad-Sadeghi; Bahman Maleki
Journal:  J Parasit Dis       Date:  2017-02-28

5.  Molecular Diagnosis of Pneumocystis jirovecii Pneumonia by Use of Oral Wash Samples in Immunocompromised Patients: Usefulness and Importance of the DNA Target.

Authors:  Lidia Goterris; Miguel Angel Mancebo Fernández; Juan Aguilar-Company; Vicenç Falcó; Isabel Ruiz-Camps; M Teresa Martín-Gómez
Journal:  J Clin Microbiol       Date:  2019-11-22       Impact factor: 5.948

Review 6.  Diagnosing Pneumocystis jirovecii pneumonia: A review of current methods and novel approaches.

Authors:  Marjorie Bateman; Rita Oladele; Jay K Kolls
Journal:  Med Mycol       Date:  2020-11-10       Impact factor: 4.076

7.  Improved detection of Pneumocystis jirovecii in upper and lower respiratory tract specimens from children with suspected pneumocystis pneumonia using real-time PCR: a prospective study.

Authors:  Catherine M Samuel; Andrew Whitelaw; Craig Corcoran; Brenda Morrow; Nei-Yuan Hsiao; Marco Zampoli; Heather J Zar
Journal:  BMC Infect Dis       Date:  2011-11-28       Impact factor: 3.090

8.  Pneumocystis jirovecii testing by real-time polymerase chain reaction and direct examination among immunocompetent and immunosuppressed patient groups and correlation to disease specificity.

Authors:  John W Wilson; Andew H Limper; Thomas E Grys; Theresa Karre; Nancy L Wengenack; Matthew J Binnicker
Journal:  Diagn Microbiol Infect Dis       Date:  2011-02       Impact factor: 2.803

9.  Asymptomatic carriage of Pneumocystis jirovecii and cytomegalovirus in lungs of immunocompetent patients.

Authors:  Michal Shteinberg; Pninit Shaked-Mishan; Amalia Kinarti; Amir Abramovitch; Anat Amital; Assaf Jacobi; Aharon E Kolup Feldmann; Maayan Shiner; Vladimir Gershtein; Gabriel Weber; Yochai Adir
Journal:  Lung       Date:  2014-09-09       Impact factor: 2.584

10.  Pneumocystis pneumonia in HIV-positive adults, Malawi.

Authors:  Joep J G van Oosterhout; Miriam K Laufer; M Arantza Perez; Stephen M Graham; Nelson Chimbiya; Phillip C Thesing; Miriam J Alvarez-Martinez; Paul E Wilson; Maganizo Chagomerana; Eduard E Zijlstra; Terrie E Taylor; Christopher V Plowe; Steven R Meshnick
Journal:  Emerg Infect Dis       Date:  2007-02       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.